GGrantIndex
← Leaderboards

Boris Dominik Juelg

Massachusetts General Hospital

$12,991,342
Attributed
$17,505,533
Total exposure
7
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $6.2M · FY201325
$10M$7.5M$5M$2.5M$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$22,813,499 · 8

By mechanism

U01$9,028,383 · 1
U19$8,661,311 · 3
R01$3,439,931 · 2
K08$937,600 · 1
P01$746,274 · 1

Most similar at Massachusetts General Hospital

Same institution · by research overlap

Others in their field

Top investigators on “Immune

Research focus

ImmuneImmune ResponseVaccinesAntigensInfectionViralT Cell ResponseT-LymphocyteImmunogenicVaccine TrialPredispositionVaccinationVaccine-Induced ImmunityHiv VaccineMacaca MulattaResponseCd4 Positive T LymphocytesVectorNeutralizing AntibodyImmunizationFuturePhenotypeImmunityMediating

Grant awards (29)

Ad26 Based Therapeutic Vaccines for HIV$1,503,450
U01 · FY2025 · AI
Research Project 2 The pregnancy AdaptOME$770,571
U19 · FY2025 · AI · contact PI
Multi-Omics Correlates of Therapeutic Vaccine Efficacy$251,823
P01 · FY2025 · AI · contact PI
Ad26 Based Therapeutic Vaccines for HIV$1,503,450
U01 · FY2024 · AI
Research Project 2 The pregnancy AdaptOME$715,267
U19 · FY2024 · AI · contact PI
Research Project 2 The pregnancy AdaptOME$600,000
U19 · FY2024 · AI · contact PI
Maternal Omics to Maximize Immunity$600,000
U19 · FY2024 · AI
Multi-Omics Correlates of Therapeutic Vaccine Efficacy$251,823
P01 · FY2024 · AI · contact PI
Optimizing HIV-specific T-cell responses by therapeutic vaccination$136,948
R01 · FY2024 · AI · contact PI
Demystifying the antiviral activity of the IgG3+ antibody response$1
R01 · FY2024 · AI · contact PI
Maternal Omics to Maximize Immunity$2,353,983
U19 · FY2023 · AI
Ad26 Based Therapeutic Vaccines for HIV$1,503,450
U01 · FY2023 · AI
Research Project 2 The pregnancy AdaptOME$796,711
U19 · FY2023 · AI · contact PI
Optimizing HIV-specific T-cell responses by therapeutic vaccination$669,944
R01 · FY2023 · AI · contact PI
Demystifying the antiviral activity of the IgG3+ antibody response$604,800
R01 · FY2023 · AI · contact PI
Multi-Omics Correlates of Therapeutic Vaccine Efficacy$242,628
P01 · FY2023 · AI · contact PI
Maternal Omics to Maximize Immunity$2,353,983
U19 · FY2022 · AI
Ad26 Based Therapeutic Vaccines for HIV$1,503,863
U01 · FY2022 · AI
Research Project 2 The pregnancy AdaptOME$470,796
U19 · FY2022 · AI · contact PI
Ad26 Based Therapeutic Vaccines for HIV$1,504,263
U01 · FY2021 · AI
Optimizing HIV-specific T-cell responses by therapeutic vaccination$706,770
R01 · FY2021 · AI · contact PI
Ad26 Based Therapeutic Vaccines for HIV$1,509,907
U01 · FY2020 · AI
Optimizing HIV-specific T-cell responses by therapeutic vaccination$682,804
R01 · FY2020 · AI · contact PI
Optimizing HIV-specific T-cell responses by therapeutic vaccination$638,664
R01 · FY2019 · AI · contact PI
Vaccine induced T-cell protection against SIV infection$200,880
K08 · FY2017 · AI · contact PI
Vaccine induced T-cell protection against SIV infection$185,090
K08 · FY2016 · AI · contact PI
Vaccine induced T-cell protection against SIV infection$185,090
K08 · FY2015 · AI · contact PI
Vaccine induced T-cell protection against SIV infection$185,090
K08 · FY2014 · AI · contact PI
Vaccine induced T-cell protection against SIV infection$181,450
K08 · FY2013 · AI · contact PI